DermaZinc Spray/Drop

Manufacturer: WynnPharm Inc
Effective date: 2025-11-14
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 01:16:16

Label at a glance#

ProductDermaZinc

Active ingredientPYRITHIONE ZINC

Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Pyrithione Zinc 0.25%

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep Out of Reach of Children.

OTC - PURPOSE SECTION

Anti-dandruff

Seborrheic Dermatitis treatment

DOSAGE & ADMINISTRATION SECTION

Apply to affected areas twice daily or as directed by a doctor.

INDICATIONS & USAGE SECTION

For relief of the symptoms of seborrheic dermatitis and dandruff.

WARNINGS SECTION

Warnings
■ For external use only.
■ Ask a doctor before use if you have a condition that covers a large area of the body.

When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with
water.
Stop use and ask a doctor if condition worsens or does not improve after regular use of this
product as directed.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.

INACTIVE INGREDIENT SECTION

Isopropyl Myristate, SD-Alcohol 40-B, Sodium Lauryl Sulfate, Undecylinic Acid

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DermaZinc Spray

Inner/Immediate Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DermaZinc Spray

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1101635	Dermazinc 0.25 % Topical Spray	PSN	4
242537	zinc pyrithione 0.25 % Topical Spray	PSN	4
1101635	zinc pyrithione 2.5 MG/ML Topical Spray [Dermazinc]	SBD	4
242537	zinc pyrithione 2.5 MG/ML Topical Spray	SCD	4
1101635	Dermazinc 0.25 % Topical Spray	SY	4
1101635	Dermazinc 2.5 MG/ML Topical Spray	SY	4
242537	zinc pyrithione 0.25 % Topical Spray	SY	4

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
35324-002-04	DermaZinc	1 in 1 BOX	SPRAY	1		4
35324-002-04	DermaZinc	120 mL in 1 BOTTLE, SPRAY	SPRAY	120		4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

DermaZinc
pyrithione zinc
ISOPROPYL MYRISTATE
UNDECYLENIC ACID
SODIUM LAURYL SULFATE
ALCOHOL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
35324-002	35324-002-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ISOPROPYL MYRISTATE	0RE8K4LNJS	IACT
UNDECYLENIC ACID	K3D86KJ24N	IACT
SODIUM LAURYL SULFATE	368GB5141J	IACT
ALCOHOL	3K9958V90M	IACT
PYRITHIONE ZINC	R953O2RHZ5	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
DermaZinc	PYRITHIONE ZINC	WynnPharm Inc	e73010ae-291d-6adf-e053-2a95a90a8aea	2025-11-14	Warnings	Exact identifier ndc (package): 35324-002-04 ndc (product): 35324-002 ndc11 (package): 35324000204 spl id: 43881568-3560-4236-e063-6394a90ab554 spl set id: e73010ae-291d-6adf-e053-2a95a90a8aea

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.